Daejung Chemicals & Metals Resultados de beneficios anteriores
Pasado controles de criterios 2/6
Daejung Chemicals & Metals has been growing earnings at an average annual rate of 14%, while the Chemicals industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 4.7% per year. Daejung Chemicals & Metals's return on equity is 6.2%, and it has net margins of 11.3%.
Información clave
14.0%
Tasa de crecimiento de los beneficios
13.7%
Tasa de crecimiento del BPA
Crecimiento de la industria Chemicals | 13.9% |
Tasa de crecimiento de los ingresos | 4.7% |
Rentabilidad financiera | 6.2% |
Margen neto | 11.3% |
Última actualización de beneficios | 30 Jun 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Daejung Chemicals & Metals (KOSDAQ:120240) Might Be Having Difficulty Using Its Capital Effectively
Aug 13Did You Miss Daejung Chemicals & MetalsLtd's (KOSDAQ:120240) Impressive 101% Share Price Gain?
Mar 05Is Daejung Chemicals & MetalsLtd (KOSDAQ:120240) Using Too Much Debt?
Feb 15Is Daejung Chemicals & MetalsLtd (KOSDAQ:120240) Likely To Turn Things Around?
Jan 31What Kind Of Investors Own Most Of Daejung Chemicals & Metals Co.,Ltd. (KOSDAQ:120240)?
Jan 15Daejung Chemicals & Metals Co.,Ltd.'s (KOSDAQ:120240) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Dec 31Are Daejung Chemicals & MetalsLtd's (KOSDAQ:120240) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 16Shareholders Of Daejung Chemicals & MetalsLtd (KOSDAQ:120240) Must Be Happy With Their 261% Total Return
Dec 01Desglose de ingresos y gastos
Cómo gana y gasta dinero Daejung Chemicals & Metals. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
30 Jun 24 | 92,170 | 10,452 | 8,741 | 1,667 |
31 Mar 24 | 92,554 | 10,584 | 8,205 | 1,655 |
31 Dec 23 | 93,283 | 12,959 | 8,071 | 1,758 |
30 Sep 23 | 93,510 | 12,679 | 8,181 | 1,019 |
30 Jun 23 | 95,275 | 14,153 | 7,606 | 1,413 |
31 Mar 23 | 95,502 | 15,425 | 7,688 | 1,448 |
31 Dec 22 | 96,608 | 13,742 | 7,664 | 1,569 |
30 Sep 22 | 97,694 | 14,856 | 7,382 | 1,945 |
30 Jun 22 | 93,968 | 13,266 | 7,323 | 1,886 |
31 Mar 22 | 94,489 | 10,156 | 8,083 | 1,686 |
31 Dec 21 | 88,929 | 8,445 | 7,973 | 1,355 |
30 Sep 21 | 85,204 | 7,090 | 8,175 | 1,074 |
30 Jun 21 | 84,001 | 6,488 | 8,089 | 945 |
31 Mar 21 | 79,740 | 8,103 | 6,927 | 799 |
31 Dec 20 | 80,192 | 8,913 | 7,076 | 828 |
30 Sep 20 | 78,703 | 5,933 | 7,177 | 799 |
30 Jun 20 | 78,693 | 6,853 | 7,186 | 780 |
31 Mar 20 | 79,698 | 6,172 | 7,405 | 912 |
31 Dec 19 | 79,607 | 6,068 | 7,219 | 956 |
30 Sep 19 | 79,719 | 9,693 | 7,459 | 1,049 |
30 Jun 19 | 78,028 | 8,999 | 7,331 | 1,304 |
31 Mar 19 | 75,573 | 10,529 | 7,024 | 1,314 |
31 Dec 18 | 73,830 | 10,037 | 6,904 | 1,381 |
30 Sep 18 | 70,900 | 8,808 | 6,413 | 1,337 |
30 Jun 18 | 69,543 | 9,402 | 6,367 | 1,221 |
31 Mar 18 | 67,627 | 8,477 | 6,207 | 1,240 |
31 Dec 17 | 66,494 | 7,329 | 6,095 | 1,173 |
30 Sep 17 | 66,314 | 9,326 | 5,957 | 1,034 |
30 Jun 17 | 64,281 | 7,916 | 5,927 | 872 |
31 Mar 17 | 62,794 | 7,018 | 5,970 | 771 |
31 Dec 16 | 60,943 | 7,524 | 6,018 | 657 |
30 Sep 16 | 59,616 | 5,482 | 6,090 | 602 |
30 Jun 16 | 59,099 | 6,677 | 5,708 | 536 |
31 Mar 16 | 58,524 | 7,446 | 5,910 | 457 |
31 Dec 15 | 57,889 | 7,653 | 5,802 | 366 |
30 Sep 15 | 59,282 | 8,224 | 5,555 | 20 |
30 Jun 15 | 61,463 | 7,949 | 5,649 | 11 |
31 Mar 15 | 61,332 | 6,811 | 5,439 | 4 |
31 Dec 14 | 60,580 | 6,519 | 5,428 | 293 |
30 Sep 14 | 59,988 | 6,178 | 5,242 | 65 |
30 Jun 14 | 57,378 | 5,675 | 5,351 | 47 |
31 Mar 14 | 57,507 | 6,178 | 5,270 | 19 |
31 Dec 13 | 57,679 | 9,797 | 5,142 | 0 |
Ingresos de calidad: A120240 has high quality earnings.
Margen de beneficios creciente: A120240's current net profit margins (11.3%) are lower than last year (14.9%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: A120240's earnings have grown by 14% per year over the past 5 years.
Acelerando crecimiento: A120240's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Beneficios vs. Industria: A120240 had negative earnings growth (-26.1%) over the past year, making it difficult to compare to the Chemicals industry average (-4.5%).
Rentabilidad financiera
Alta ROE: A120240's Return on Equity (6.2%) is considered low.